prednisolone has been researched along with Bacteremia in 18 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
Bacteremia: The presence of viable bacteria circulating in the blood. Fever, chills, tachycardia, and tachypnea are common acute manifestations of bacteremia. The majority of cases are seen in already hospitalized patients, most of whom have underlying diseases or procedures which render their bloodstreams susceptible to invasion.
| Excerpt | Relevance | Reference |
|---|---|---|
| "112 patients admitted to hospital with a diagnosis of erysipelas, were randomized to 8 days treatment with prednisolone or placebo in addition to antibiotics." | 9.08 | Antibiotic and prednisolone therapy of erysipelas: a randomized, double blind, placebo-controlled study. ( Bergkvist, PI; Sjöbeck, K, 1997) |
| "112 patients admitted to hospital with a diagnosis of erysipelas, were randomized to 8 days treatment with prednisolone or placebo in addition to antibiotics." | 5.08 | Antibiotic and prednisolone therapy of erysipelas: a randomized, double blind, placebo-controlled study. ( Bergkvist, PI; Sjöbeck, K, 1997) |
| "Adolescents and young adults (AYAs) with acute lymphoblastic leukemia (ALL) are more likely to have chemotherapy-related complications than children." | 1.62 | Comparison of myelosuppression using the D-index between children and adolescents/young adults with acute lymphoblastic leukemia during induction chemotherapy. ( Hori, D; Kobayashi, K; Kobayashi, R; Kodama, K; Matsushima, S; Sano, H; Suzuki, D; Yanagi, M, 2021) |
| "No increased frequency of infection was seen for the children with genotypes encoding serum low levels of MBL." | 1.33 | Infections during induction therapy of childhood acute lymphoblastic leukemia--no association to mannose-binding lectin deficiency. ( Andreassen, B; Garred, P; Lausen, B; Madsen, HO; Schmiegelow, K, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (11.11) | 18.7374 |
| 1990's | 5 (27.78) | 18.2507 |
| 2000's | 4 (22.22) | 29.6817 |
| 2010's | 6 (33.33) | 24.3611 |
| 2020's | 1 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Matsushima, S | 1 |
| Kobayashi, R | 1 |
| Sano, H | 1 |
| Hori, D | 1 |
| Yanagi, M | 1 |
| Kodama, K | 1 |
| Suzuki, D | 1 |
| Kobayashi, K | 1 |
| van der Vusse, ML | 1 |
| van Son, WJ | 1 |
| Ott, A | 1 |
| Manson, W | 1 |
| Kletke, SN | 1 |
| Brissette, AR | 1 |
| Gale, J | 1 |
| Ishida, T | 1 |
| Morita, Y | 1 |
| Hoshi, N | 1 |
| Yoshizaki, T | 1 |
| Ohara, Y | 1 |
| Kawara, F | 1 |
| Tanaka, S | 1 |
| Yamamoto, Y | 1 |
| Matsuo, H | 1 |
| Iwata, K | 1 |
| Toyonaga, T | 1 |
| Azuma, T | 1 |
| Jones, N | 1 |
| Hoshina, D | 1 |
| Tsujiwaki, M | 1 |
| Furuya, K | 1 |
| Kawamura, T | 1 |
| Kaneko, K | 1 |
| Nonomura, Y | 1 |
| Watanabe, K | 1 |
| Koike, R | 1 |
| Kubota, T | 1 |
| Harigai, M | 1 |
| Inoue, Y | 1 |
| Iwai, T | 1 |
| Miyasaka, N | 1 |
| Kitazawa, K | 1 |
| Honda, A | 1 |
| Arahata, Y | 1 |
| Kimura, K | 1 |
| Arakawa, Y | 1 |
| Van Zonneveld, M | 1 |
| Droogh, JM | 1 |
| Fieren, MW | 1 |
| Gyssens, IC | 1 |
| Van Gelder, T | 1 |
| Weimar, W | 1 |
| VOIT, K | 1 |
| LEGRAND, R | 1 |
| DESRUELLES, J | 1 |
| GERARD, A | 1 |
| BUTAEYE, P | 1 |
| BERTRAND, M | 1 |
| Chizuka, A | 1 |
| Kami, M | 1 |
| Kanda, Y | 1 |
| Murashige, N | 1 |
| Kishi, Y | 1 |
| Hamaki, T | 1 |
| Kim, SW | 1 |
| Hori, A | 1 |
| Kojima, R | 1 |
| Mori, SI | 1 |
| Tanosaki, R | 1 |
| Gomi, H | 1 |
| Takaue, Y | 1 |
| Lausen, B | 1 |
| Schmiegelow, K | 1 |
| Andreassen, B | 1 |
| Madsen, HO | 1 |
| Garred, P | 1 |
| Taylor, G | 1 |
| Goodfield, MJ | 1 |
| Bergkvist, PI | 1 |
| Sjöbeck, K | 1 |
| Leccia, MT | 1 |
| Aubry-Artignan, S | 1 |
| Brion, JP | 1 |
| Voirin, L | 1 |
| Beani, JC | 1 |
| Amblard, P | 1 |
| Matsumori, A | 1 |
| Nishiya, K | 1 |
| Tahara, K | 1 |
| Tanaka, Y | 1 |
| Yamasaki, H | 1 |
| Hashimoto, K | 1 |
| Klauser, R | 1 |
| Zlabinger, GJ | 1 |
| Traindl, O | 1 |
| Franz, M | 1 |
| Watschinger, B | 1 |
| Pohanka, E | 1 |
| Kudlacek, S | 1 |
| Kovarik, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Use of Corticosteroids in Children Hospitalized With Cellulitis: Randomized, Double Blind, Placebo Controlled Trial[NCT02087527] | 19 participants (Actual) | Interventional | 2014-06-30 | Terminated (stopped due to Calculated sample size not achieved) | |||
| Use of a Single Dose of Oral Prednisone in the Treatment of Cellulitis[NCT01671423] | 42 participants (Actual) | Interventional | 2012-08-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Number of times the subject needed to use pain medication between day 1 and the 48 hour follow-up (NCT01671423)
Timeframe: Assessed once during the 48 hour follow-up
| Intervention | medications taken (Median) |
|---|---|
| Prednisone | 7 |
| Placebo | 2 |
The level of pain as measured by a Visual Analog Scale(VAS) measured once at day 1 and once during the 48th hour follow-up visit. Minimum value 0, maximum value 100mm, higher scores corresponds to more pain/worse outcomes. (NCT01671423)
Timeframe: Assessed once at day 1 and then once during the 48 hour follow-up
| Intervention | score on a scale (Mean) | |
|---|---|---|
| VAS at Day 1 | VAS at 48 hrs | |
| Placebo | 56.45 | 25.91 |
| Prednisone | 79.64 | 39.71 |
2 trials available for prednisolone and Bacteremia
| Article | Year |
|---|---|
Antibiotic and prednisolone therapy of erysipelas: a randomized, double blind, placebo-controlled study.
Topics: Anti-Inflammatory Agents; Bacteremia; Double-Blind Method; Drug Therapy, Combination; Erysipelas; Fe | 1997 |
Antibiotic and prednisolone therapy of erysipelas: a randomized, double blind, placebo-controlled study.
Topics: Anti-Inflammatory Agents; Bacteremia; Double-Blind Method; Drug Therapy, Combination; Erysipelas; Fe | 1997 |
Antibiotic and prednisolone therapy of erysipelas: a randomized, double blind, placebo-controlled study.
Topics: Anti-Inflammatory Agents; Bacteremia; Double-Blind Method; Drug Therapy, Combination; Erysipelas; Fe | 1997 |
Antibiotic and prednisolone therapy of erysipelas: a randomized, double blind, placebo-controlled study.
Topics: Anti-Inflammatory Agents; Bacteremia; Double-Blind Method; Drug Therapy, Combination; Erysipelas; Fe | 1997 |
Influence of immunosuppressive therapy on infectious complications in renal transplant recipients.
Topics: Adult; Antilymphocyte Serum; Azathioprine; Bacteremia; Cyclosporine; Female; Graft Rejection; Humans | 1992 |
16 other studies available for prednisolone and Bacteremia
| Article | Year |
|---|---|
Comparison of myelosuppression using the D-index between children and adolescents/young adults with acute lymphoblastic leukemia during induction chemotherapy.
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bac | 2021 |
Helicobacter canis bacteremia in a renal transplant patient.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Cefuroxime; Ciprofloxacin; DNA, Bacterial; DNA, Ribosomal; | 2014 |
Endogenous bacterial endophthalmitis caused by Pantoea species: a case report.
Topics: Administration, Topical; Anti-Bacterial Agents; Bacteremia; Drug Therapy, Combination; Endophthalmit | 2014 |
Disseminated nocardiosis during systemic steroid therapy for the prevention of esophageal stricture after endoscopic submucosal dissection.
Topics: Administration, Oral; Aged, 80 and over; Bacteremia; Dissection; Dose-Response Relationship, Drug; D | 2015 |
Sepsis During Immunosuppression for Sight-threatening Uveitis: The Flip side.
Topics: Adult; Aged; Azathioprine; Bacteremia; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immu | 2018 |
Erythema multiforme associated with Trueperella pyogenes bacteremia.
Topics: Actinomycetales Infections; Aged; Anti-Bacterial Agents; Bacteremia; Diagnosis, Differential; Drug T | 2017 |
Infected abdominal aortic aneurysm caused by nontyphoid Salmonella in an immunocompromised patient with rheumatoid arthritis.
Topics: Aged; Anti-Inflammatory Agents; Aortic Aneurysm, Abdominal; Arthritis, Rheumatoid; Bacteremia; Human | 2009 |
[Group B streptococcal bacteremia in a 10-year-old girl undergoing corticosteroid therapy].
Topics: Bacteremia; Child; Female; Glucocorticoids; Humans; Prednisolone; Purpura, Thrombocytopenic, Idiopat | 2010 |
Yersinia pseudotuberculosis bacteraemia in a kidney transplant patient.
Topics: Anti-Infective Agents; Bacteremia; Ciprofloxacin; Cyclosporine; Humans; Immunosuppressive Agents; Ki | 2002 |
[Cortisone therapy of severe acute infectious diseases].
Topics: Acute Disease; Bacteremia; Cortisone; Humans; Prednisolone; Prednisone; Sepsis; Virus Diseases | 1958 |
[Cure of Proteus septicemia with purpuric manifestations].
Topics: Anti-Bacterial Agents; Bacteremia; Humans; Prednisolone; Proteus; Proteus Infections; Sepsis | 1960 |
Value of surveillance blood culture for early diagnosis of occult bacteremia in patients on corticosteroid therapy following allogeneic hematopoietic stem cell transplantation.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Age Factors; Aged; Bacteremia; Bacteria; Bacteriological | 2005 |
Infections during induction therapy of childhood acute lymphoblastic leukemia--no association to mannose-binding lectin deficiency.
Topics: Adolescent; Age Factors; Allopurinol; Anti-Infective Agents; Antineoplastic Combined Chemotherapy Pr | 2006 |
Fatal salmonellosis in systemic lupus erythematosus.
Topics: Aged; Bacteremia; Fatal Outcome; Female; Glucocorticoids; Humans; Lupus Erythematosus, Systemic; Pre | 1995 |
[Salmonella enteritidis septicemia manifesting as a suppurated thrombophlebitis].
Topics: Aged; Anti-Inflammatory Agents; Bacteremia; Female; Humans; Immunocompromised Host; Necrosis; Predni | 1998 |
[A case of pityriasis rubra pilaris associated with unclassified connective tissue disease and sepsis in clinical course].
Topics: Adult; Antibodies, Antinuclear; Bacteremia; Biomarkers; Carrier State; Connective Tissue Diseases; E | 1998 |